GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $753,000 | 0.0% | 17,305 | 0.0% | 0.38% | +12.4% |
| Q1 2022 | $753,000 | -1.3% | 17,305 | 0.0% | 0.34% | -0.3% |
| Q4 2021 | $763,000 | +12.2% | 17,305 | -2.8% | 0.34% | +1.5% |
| Q3 2021 | $680,000 | -4.1% | 17,805 | 0.0% | 0.34% | -0.6% |
| Q2 2021 | $709,000 | +6.1% | 17,805 | -4.8% | 0.34% | +3.7% |
| Q1 2021 | $668,000 | -6.4% | 18,705 | -3.6% | 0.32% | -14.5% |
| Q4 2020 | $714,000 | -8.3% | 19,405 | -6.3% | 0.38% | -16.8% |
| Q3 2020 | $779,000 | -10.8% | 20,714 | -3.3% | 0.46% | -15.4% |
| Q2 2020 | $873,000 | +4.2% | 21,414 | -3.2% | 0.54% | -3.9% |
| Q1 2020 | $838,000 | -19.5% | 22,114 | -0.2% | 0.56% | +6.4% |
| Q4 2019 | $1,041,000 | +10.0% | 22,164 | 0.0% | 0.53% | +5.6% |
| Q3 2019 | $946,000 | +6.2% | 22,164 | -0.4% | 0.50% | +5.7% |
| Q2 2019 | $891,000 | +1.6% | 22,264 | +6.1% | 0.47% | +0.6% |
| Q1 2019 | $877,000 | +4.4% | 20,991 | -4.5% | 0.47% | -2.1% |
| Q4 2018 | $840,000 | -12.8% | 21,991 | -8.3% | 0.48% | +3.4% |
| Q3 2018 | $963,000 | +0.4% | 23,991 | +0.8% | 0.46% | -5.7% |
| Q2 2018 | $959,000 | +6.6% | 23,791 | +3.3% | 0.49% | +4.9% |
| Q1 2018 | $900,000 | +11.2% | 23,030 | +0.9% | 0.47% | +15.0% |
| Q4 2017 | $809,000 | -21.3% | 22,830 | -9.9% | 0.41% | -22.9% |
| Q3 2017 | $1,028,000 | -5.9% | 25,330 | 0.0% | 0.53% | -9.3% |
| Q2 2017 | $1,092,000 | +2.2% | 25,330 | 0.0% | 0.58% | +2.1% |
| Q1 2017 | $1,068,000 | +12.5% | 25,330 | +2.8% | 0.57% | +7.1% |
| Q4 2016 | $949,000 | -11.4% | 24,630 | -0.8% | 0.53% | -13.5% |
| Q3 2016 | $1,071,000 | -1.7% | 24,830 | -1.2% | 0.62% | -1.8% |
| Q2 2016 | $1,089,000 | +7.0% | 25,130 | +0.1% | 0.63% | +2.6% |
| Q1 2016 | $1,018,000 | +5.5% | 25,104 | +5.0% | 0.61% | +2.0% |
| Q4 2015 | $965,000 | +9.3% | 23,915 | +4.1% | 0.60% | +4.7% |
| Q3 2015 | $883,000 | -11.6% | 22,965 | -0.7% | 0.57% | -2.6% |
| Q2 2015 | $999,000 | +2.5% | 23,133 | +9.5% | 0.59% | +7.3% |
| Q1 2015 | $975,000 | +28.8% | 21,130 | +19.2% | 0.55% | +33.1% |
| Q4 2014 | $757,000 | +5.0% | 17,730 | +13.1% | 0.41% | +7.3% |
| Q3 2014 | $721,000 | – | 15,680 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |